News Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor CAR T Outcomes
News Clinical Trial Builds on Prior Promising Results of Iberdomide in Patients with Relapsed/Refractory Multiple Myeloma
News Study Compiling Outcomes of 17,000 Cancer Patients Highlights Need for Careful Treatment Planning, Monitoring
News Administered Earlier, Cilta-Cel CAR T Produces Deep, Durable Responses in Multiple Myeloma Patients
News Experts in Transplantation, Engineered Cells and Pediatrics Join Growing Roswell Park Cell Therapy Program
BROADCASTMED